Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Colopy

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutic Innovation & Regulatory Science|September 8, 2023
Planning Benefit-Risk Assessments Using VisualizationsMichael W Colopy, Lovemore Gakava, Chen Chen
Drug Safety|June 14, 2019
Pooling Different Safety Data Sources: Impact of Combining Solicited and Spontaneous Reports on Signal Detection In PharmacovigilanceJeremy D Jokinen, Rosalind J Walley, Michael W Colopy, et al.
Therapeutic Innovation & Regulatory Science|July 12, 2018
Statistical Practices of Safety Monitoring: An Industry SurveyMichael W Colopy, Robert Gordon, Faiz Ahmad, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Benefit-Risk Evaluation and Decision Making: Some Practical InsightsMichael W Colopy, C V Damaraju, Weili He, et al.
Spine|April 2, 2008
Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injuryFrancois Giuliano, Eusebio Rubio-Aurioles, Michael Kennelly, et al.
Clinical Therapeutics|November 18, 2005
Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysisDimitrios G Hatzichristou, Philip Aliotta, Stephen Auerbach, et al.
BJU International|December 22, 2004
Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trialCulley C Carson, Dimitrios G Hatzichristou, Serge Carrier, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|September 8, 2023
Planning Benefit-Risk Assessments Using VisualizationsMichael W Colopy, Lovemore Gakava, Chen Chen
Drug Safety|June 14, 2019
Pooling Different Safety Data Sources: Impact of Combining Solicited and Spontaneous Reports on Signal Detection In PharmacovigilanceJeremy D Jokinen, Rosalind J Walley, Michael W Colopy, et al.
Therapeutic Innovation & Regulatory Science|July 12, 2018
Statistical Practices of Safety Monitoring: An Industry SurveyMichael W Colopy, Robert Gordon, Faiz Ahmad, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Benefit-Risk Evaluation and Decision Making: Some Practical InsightsMichael W Colopy, C V Damaraju, Weili He, et al.
Spine|April 2, 2008
Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injuryFrancois Giuliano, Eusebio Rubio-Aurioles, Michael Kennelly, et al.
Clinical Therapeutics|November 18, 2005
Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysisDimitrios G Hatzichristou, Philip Aliotta, Stephen Auerbach, et al.
BJU International|December 22, 2004
Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trialCulley C Carson, Dimitrios G Hatzichristou, Serge Carrier, et al.
Pageof 1